IHAB HAJJAR to Amyloid beta-Peptides
This is a "connection" page, showing publications IHAB HAJJAR has written about Amyloid beta-Peptides.
Connection Strength
1.517
-
Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment. JAMA Netw Open. 2019 12 02; 2(12):e1917363.
Score: 0.547
-
The NIH toolbox emotion battery and cerebrospinal fluid biomarkers in Alzheimer's disease: findings from the multisite ARMADA study. J Gerontol B Psychol Sci Soc Sci. 2026 01 12; 81(2).
Score: 0.209
-
Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African Americans. Ann Neurol. 2024 09; 96(3):463-475.
Score: 0.187
-
Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors. JAMA Netw Open. 2022 10 03; 5(10):e2235068.
Score: 0.166
-
Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment. J Alzheimers Dis. 2020; 77(2):843-853.
Score: 0.137
-
Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease. J Alzheimers Dis. 2019; 72(2):507-514.
Score: 0.128
-
Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment. JAMA Neurol. 2015 Sep; 72(9):1069-70.
Score: 0.102
-
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain. 2022 06 30; 145(6):1924-1938.
Score: 0.041